CT2 Program Lecture Series

All lectures are on Tuesdays from 12 to 1 p.m. in Comer Commons at Moores Cancer Center (directions and map). Lunch is available at 11:45 a.m. for those attending the lecture. 

Principles of Cancer Drug Therapeutics Development

This is a series of weekly lectures delivered by CT2 and UC San Diego faculty members focusing on the necessary sequential steps involved in drug development.

Topics in Cancer Drug Development

This is a series of lectures by industry leaders in cancer drug development. The goal is to expose trainees to experts with a substantial track record in the “real life” challenges of cancer drug development. The lecturers are typically CEOs, directors of research, or medical directors from companies in the San Diego biomedical community, although experts from large pharmaceutical companies have also participated. The outside speakers are invited to discuss challenges of developing a given target or novel therapeutic and give fellows an opportunity to hear the story of the development of specific therapeutic agents.

Upcoming Lectures

Date Speaker Affiliation Title
​Danelle James, MD
​Head of Clinical Science, Pharmacyclics
​Evolution of a Therapeutic Landscape, BTK Inhibition in CLL
​Yi Lui, PhD
​CEO, Wellspring Biosciences
​Targeting KRAS Mutant Cancers with a Covalent G12C-specific Inhibitor
​Ted Johnson, PhD
​The Discovery of Lorlatinib, a Brain Penetrant Macrocyclic ALK/ROS1 Inhibitor for the Treatment of Resistant and Metastatic NSCLC
Richard Schwab, MD​​UCSD
​Targeted Therapy for Breast Cancer
Pablo Tamayo, MD​​UCSD
​Synthetic Lethality Revisited
David Cheresh, PhD
​Targeting Cancer Drug Resistance - Exploiting a connection between tissue repair and cancer progression
​Karen Messer, PhD
​Design of Phase I and II Clinical Trials
​Troy Wilson, PhD, JD
​Development of Farnesyl Transferase Inhibitors
​Tannishtha Reya, PhD
New Models for Imaging Cancer Stem Cells and Therapy Resistance in Real Time​
Huawei Wang, PhD​​UCSD
​Cell-based Therapeutics to Treat Metastatic Cancer
​Tariq Rana, PhD
​Genome-wide microRNA and CRISPR Screens for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers

Schedules for previous years